Music |
Video |
Movies |
Chart |
Show |
KRAS G12C Inhibitors: Acquired Resistance and Combo Strategies (Targeted Oncology) View | |
Mechanisms of acquired resistance to KRAS G12C inhibition in cancer (ecancer) View | |
Mitigating resistance in KRAS-driven cancers (VJOncology) View | |
Adagrasib shows CNS penetration and encouraging intracranial activity for KRASG12C-mutated NSCLC (ecancer) View | |
KRAS G12C Inhibition in Advanced NSCLC: AMG 510 (Targeted Oncology) View | |
Safety of sotorasib and panitumumab in advanced KRAS p.G12C-mutated colorectal cancer (ecancer) View | |
The potential of KRAS inhibitors for non-small-cell lung cancer (ecancer) View | |
KRAS-Mutant NSCLC (OncLive) View | |
CRSF 7th Masterclass | Resistance to KRAS TKI u0026 Post-Resistance Therapy by Dr. Soumya Surath Panda (CRSF - Cancer Research and Statistic Foundation) View | |
Update on NDA in GIST, Promising Data in Lung Cancer, KRAS G12C-Mutant Cancers, and AML, and More (OncLive) View |